These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1318 related items for PubMed ID: 16280760

  • 1. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [Abstract] [Full Text] [Related]

  • 2. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [Abstract] [Full Text] [Related]

  • 3. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [Abstract] [Full Text] [Related]

  • 4. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.
    Ferrari MK, McNeal JE, Malhotra SM, Brooks JD.
    Urology; 2004 Oct; 64(4):749-53. PubMed ID: 15491714
    [Abstract] [Full Text] [Related]

  • 5. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ, Wieder JA, Jack GS, Dorey F, deKernion JB, Aronson WJ.
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [Abstract] [Full Text] [Related]

  • 6. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
    Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L.
    Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens.
    May M, Kaufmann O, Hammermann F, Loy V, Siegsmund M.
    BJU Int; 2007 Mar; 99(3):539-44. PubMed ID: 17155973
    [Abstract] [Full Text] [Related]

  • 8. Visual estimation of tumour extent is not an independent predictor of prostate specific antigen recurrence.
    Jones TD, Koch MO, Lin H, Cheng L.
    BJU Int; 2005 Dec; 96(9):1253-7. PubMed ID: 16287440
    [Abstract] [Full Text] [Related]

  • 9. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC, SEARCH Database Study Group.
    J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
    [Abstract] [Full Text] [Related]

  • 10. [Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors].
    Feyaerts A, Delrée A, Lorge F, Opsomer RJ, Wese FX, Van Cangh PJ, Draguet AP, Cosyns JP.
    Acta Urol Belg; 1997 Mar; 65(1):11-8. PubMed ID: 9245198
    [Abstract] [Full Text] [Related]

  • 11. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
    D'Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP.
    J Urol; 2001 Jan; 165(1):126-9. PubMed ID: 11125380
    [Abstract] [Full Text] [Related]

  • 12. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M, Hayasaka S, Taylor JM, Shah R, Proverbs-Singh T, Manley S, Rubin MA.
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
    Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O'Neill GF, Turner JJ, Delprado W, Grygiel JJ, Sutherland RL, Stricker PD.
    Cancer; 2003 Apr 15; 97(8):1884-93. PubMed ID: 12673714
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.
    Pierorazio PM, Lambert SM, Matsukhani M, Sprenkle PC, McCann TR, Katz AE, Olsson CA, Benson MC, McKiernan JM.
    BJU Int; 2007 Nov 15; 100(5):1066-70. PubMed ID: 17784880
    [Abstract] [Full Text] [Related]

  • 16. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ, Presti JC, Terris MK, Kane CJ, Aronson WJ, Dorey F, Amling CL, SEARCH Database Study Group.
    J Urol; 2003 Jun 15; 169(6):2129-35. PubMed ID: 12771734
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy.
    Freedland SJ, Aronson WJ, Presti JC, Amling CL, Terris MK, Trock B, Kane CJ.
    Cancer; 2004 Apr 15; 100(8):1633-8. PubMed ID: 15073850
    [Abstract] [Full Text] [Related]

  • 19. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
    Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
    [Abstract] [Full Text] [Related]

  • 20. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
    Miyake H, Sakai I, Harada K, Eto H, Hara I.
    Hinyokika Kiyo; 2005 Apr 15; 51(4):241-6. PubMed ID: 15912782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.